Close
Close

Rare Disease Innovation Summit

2.84
2.9 from 26 votes
Date: 19 - 20 June, 2018
Location: Boston, USA

Patient-Centric Strategies for Early Access and Product Launch

With the acceleration of the development of rare disease therapies and the rise of new technologies and innovations, there is not a better time to come together to strategize ways to effectively launch best in class products, promote patient access and maximize commercial success. CBI's Rare Disease Innovation Summit brings together diverse stakeholders to discuss the most pressing challenges in developing and launching orphan drugs. The forum delves into the complexities of applying a patient-centric approach to move rare disease therapies from development through commercialization, including early access and product launch.


Key Insights and Takeaways:

Hear case studies from industry leaders on best practices for commercialization and market access
Delve into strategies for demonstrating value for orphan drugs to payers and regulatory bodies
Learn about innovative multi-stakeholder partnership models and how to best leverage those to accelerate drug development and patient access
Understand the complex regulatory environment for expedited reviews, accelerated pathways and early access
Evaluate best practices for identifying and engaging with patients in limited patient populations
Discuss innovations in rare disease drug development and how they can contribute to successful commercialization and market access
Examine strategies for improving patient access and outcomes through engagement and support

2.84
2.9 from 26 votes